Christina Y. Miyake, MD, MS
Director, Genetics Arrhythmia Program
Associate Professor, Baylor College of Medicine
Get to know Christina Y. Miyake, MD, MS
Dr. Miyake is an Associate Professor and is the Director of the Cardiovascular Genetics Arrhythmia Program at Texas Children’s Hospital. She is also a member of the Arrhythmia and Pacing (Electrophysiology) Service at Texas Children's Hospital. She specializes in the care of pediatric and adult congenital patients with cardiac arrhythmia disorders. Dr. Miyake is also an Associate Professor in the Department of Molecular Physiology and Biophysics at Baylor College of Medicine and is actively involved in basic and translational research, with a particular focus on identifying the genetic and molecular basis of heritable arrhythmia disorders. Her long-term goal is to leverage her clinical, basic, and genetic expertise to advance treatment and improve the quality of care and outcomes among patients with arrhythmia disorders.
Her clinical practice largely involves pediatric patients with heritable arrhythmia disorders including Long QT syndrome, Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), Brugada Syndrome, Arrhythmogenic Cardiomyopathy (AC/ARVD), left ventricular non-compaction and hypertrophic cardiomyopathy. She helps lead the TANGO2 team at Texas Children’s Hospital. She also serves as a consultant to the Harris County Institute of Forensic Sciences, helping families who have suffered the sudden death of loved ones. The Baby Ray Charity Fund set up by Diana and Ray Skaggs after losing their son provides help for these families to get genetic testing, clinical evaluation, and supports research into sudden death disorders. Dr. Miyake’s research helps children and families with arrhythmia conditions without a diagnosis and has helped to discover two new heritable disorders caused by genetic alterations in TANGO2 and EXOSC5. In addition, she has an interest and has published several studies in supraventricular tachycardia, Wolff-Parkinson-White Syndrome and AV block.
She participates at a national level and was involved in the writing of the national guidelines for ablation of supraventricular tachycardia (SVT) in pediatric patients1 as well as the diagnosis and treatment of hypertrophic cardiomyopathy.2
Dr. Miyake is dedicated to her patients and the care she provides. She continually strives to advance the field to improve the quality of care and outcomes for all patients with arrhythmia disorders.
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.